Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

2014
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-14T23:19:44
publisher: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study
label: RDF description of Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study - http://research.umh.es/vivo/pub/articulo/150150

Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study
type: Document
type: Generically Dependent Continuant
type: Entity
type: Academic Article
related by: AutorExt:242942_2014-Artículo:150150
date time value: 150150 pubdate
has publication venue: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
related by: AutorExt:242943_2014-Artículo:150150
related by: Autor:36736-Artículo:150150
related by: AutorExt:242934_2014-Artículo:150150
type: Thing
related by: AutorExt:242949_2014-Artículo:150150
related by: AutorExt:242937_2014-Artículo:150150
type: 2014
most specific type: Academic Article
related by: AutorExt:242947_2014-Artículo:150150
related by: AutorExt:242946_2014-Artículo:150150
related by: AutorExt:242941_2014-Artículo:150150
type: Anualidad
related by: AutorExt:242950_2014-Artículo:150150
related by: AutorExt:242939_2014-Artículo:150150
type: Continuant
type: Article
page start: 1
related by: AutorExt:242936_2014-Artículo:150150
related by: AutorExt:242945_2014-Artículo:150150
related by: AutorExt:242938_2014-Artículo:150150
most specific type: 2014
ARG_2000028: 150150 vcard
page end: 2
related by: Autor:128500-Artículo:150150
related by: AutorExt:242944_2014-Artículo:150150
type: Information Content Entity
related by: AutorExt:242940_2014-Artículo:150150

AutorExt:242942_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
type: Collection
type: Information Content Entity
type: Periodical
type: Journal
publication venue for: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study
type: Thing
type: Generically Dependent Continuant
type: Entity
type: Continuant

AutorExt:242943_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

Autor:36736-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242934_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242949_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242937_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242947_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242946_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242941_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242950_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242939_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242936_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242945_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242938_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

Autor:128500-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242944_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study

AutorExt:242940_2014-Artículo:150150
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients.The BITER Study